APA (7th ed.) Citation

Liang, X., Bu, J., Jiang, Y., Zhu, S., Ye, Q., Deng, Y., . . . Liu, Q. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: Potential role for individualized adjuvant systemic treatment. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Liang, Xuexia, Juyuan Bu, Yanhui Jiang, Shuqin Zhu, Qing Ye, Yun Deng, Wuzhu Lu, and Qiaodan Liu. Prognostic Significance of Pan-immune-inflammation Value in Hepatocellular Carcinoma Treated by Curative Radiofrequency Ablation: Potential Role for Individualized Adjuvant Systemic Treatment. Taylor & Francis Group.

MLA (9th ed.) Citation

Liang, Xuexia, et al. Prognostic Significance of Pan-immune-inflammation Value in Hepatocellular Carcinoma Treated by Curative Radiofrequency Ablation: Potential Role for Individualized Adjuvant Systemic Treatment. Taylor & Francis Group.